HBA Announces 2024 Woman of the Year
The Healthcare Businesswomen’s Association will honor the recipient at an event later this year in New York City.
Source: HBA
Dr. Yvonne Greenstreet is the 2024 Healthcare Businesswomen’s Association (HBA) Woman of the Year.
Greenstreet is the CEO of Alnylam, a pharmaceutical company focused on developing RNA interference therapeutics. The HBA also named Dr. Otis Johnson as its honorable mentor of the year, and awarded Dr. Katherine Schoenborn its annual STAR honor.
The HBA will honor Greenstreet at its annual Woman of the Year event, which will take place on May 10 in New York City. The event will also be broadcast for remote attendees across the globe.
In a press release shared with Pharmaceutical Executive, HBA CEO Mary Stutts said, “The HBA is proud to recognize and showcase this year’s award recipients for their notable and remarkable commitment and valuable contributions to women in the healthcare ecosystem. These three outstanding individuals are trailblazers, advocates, and true leaders in their respective careers and are clearly deserving of respect, admiration, and appreciation from all of us at the global HBA and throughout the industry.”
The press release explains that Greenstreet earned the honor due to her work as a leader in the pharmaceutical industry. As CEO, she has helped Alnylam earn recognition, such as being named as one of Fortune’s best workplaces for women. The company is also named as one of America’s most responsible companies by Newsweek, among other honors.
Greenstreet is a member of the board of directors for The American Funds, along with being a member of the Bill and Melinda Gates Foundation Scientific Advisory Committee.
The HBA’s honorable mentor of the year, Dr. Otis Johnson, is a co-founder and principal consultant at Trial Equity. Each year, the HBA grants the title of mentor of the year to a member of the industry who has shown themselves to be an ally by advancing, promoting, and mentoring women in the industry.
Johnson previously worked as the chief diversity, equity, inclusion, and sustainability officer at Clario. During his time there, his work helped elevate the company’s EcoVadis status. His achievements in the role include advancing pay equity and improving the balance of gender in leadership roles.
As an advisory member of the HBA’s global advisory board, Johnson is credited with amplifying underrepresented voices.
The HBA’s 2023 Strategic Transformation Achievement Recognition (STAR) volunteer recipient, Dr. Katherine Schoenborn, is the chair emerita of HBA Europe. Schoenborn earned the honor for her work in various HBA leadership roles, during which she has co-founded and lead various chapters and branches of the HBA across Europe.
Sources
(Jan. 9, 2024); HBA; 2024 Woman of the Year Yvonne Greenstreet; https://hbanet.org/our-impact/hba-awards/hba-woman-year/2024-woman-year-yvonne-greenstreet
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
